UNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington, D.C. 20549 FORM 8-K CURRENT REPORTPursuant to Section 13 or 15(d) of the...
NEW YORK and SAN DIEGO, Jan. 12, 2015 (GLOBE NEWSWIRE) -- NeoStem, Inc. (Nasdaq:NBS), a leader in the...
INVESTOR ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Neostem, Inc. Regarding Possible Breaches of Fiduciary...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may...
UNITED STATESSECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-QxQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d...
BioLife Solutions Biopreservation Media Products Used at NeoStem Subsidiary Progenitor Cell Therapy HypoThermosol® and CryoStor® Embedded in...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.